Results 101 to 110 of about 2,071 (187)
Entwicklung neuer dualer Kinasehemmstoffe gegen Clk1, Dyrk1A und Dyrk1B
Dyrk1A, a kinase from the CMGC group of kinases was recently identified as potential drug target for the treatment of Down Syndrome (DS) related Alzheimer’s Disease.
Schmitt, Christian
core +1 more source
Computer-aided drug discovery/design (CADD) techniques allow the identification of natural products that are capable of modulating protein functions in pathogenesis-related pathways, constituting one of the most promising lines followed in drug discovery.
Laura Llorach-Pares +3 more
doaj +1 more source
(A) The distribution of SRSF2 (green) in cells transfected with Cerulean-Clk1 (cyan) or mCherry-SRPK1 (magenta). DIC in grey. Bar = 5 μm. (B) Recovery curves of the YFP-MS2 mRNA FRAP measurements performed on the E3 and E6 transcription sites under ...
Shani Nadav-Eliyahu (8039129) +5 more
core +1 more source
Clk1 mRNA splice variant levels in differentiating 3T3-L1 adipocytes.
Pre-adipocytes were grown to confluence before initiating differentiation on day 0 with insulin, isobutylmethyxantine and methylxanthine as described in Methods. A. A schematic of Clk/Sty or Clk1.
Jacqueline Romero (290584) +6 more
core +1 more source
DYRK1A is a pleiotropic protein kinase with diverse functions in cellular regulation, including cell cycle control, neuronal differentiation, and synaptic transmission.
Katharina Rüben +5 more
doaj +1 more source
Collectin liver 1 (CL-L1, alias CL-10) and collectin kidney 1 (CL-K1, alias CL-11), encoded by the COLEC10 and COLEC11 genes, respectively, are highly homologous soluble pattern recognition molecules in the lectin pathway of complement.
Rafael Bayarri-Olmos +6 more
doaj +1 more source
Single mutant sites on Clk1 cDNA alter phosphorylation of SR proteins.
Plasmids of single Akt site mutants of Clk1 were transfected into 3T3-L1 cells. Clk1 substrate phosphorylation levels were probed using a monoclonal antibody recognizing the Clk phosphorylation motif, mAb104, during differentiation.
Jacqueline Romero (290584) +6 more
core +1 more source
Alternative mRNA splicing is a mechanism to regulate protein isoform expression and is regulated by alternative splicing factors. The alternative splicing factor 45 (SPF45) is overexpressed in cancer, although few biological effects of SPF45 are known ...
Al-Ayoubi, Adnan M +7 more
core +1 more source
Data from CLK1 Activates YAP to Promote Intrahepatic Cholangiocarcinogenesis
<div>Abstract<p>Cdc2-like kinase 1 (CLK1) has dual-specificity kinase ability to phosphorylate tyrosine and serine/threonine protein residues. CLK1 regulates many physiologic processes and has been shown to contribute to multiple types of cancer.
Haichuan Wang +12 more
openaire +1 more source

